GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 64 filers reported holding GALENA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,000 | – | 5,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EQUITEC SPECIALISTS, LLC | 358,600 | $696,000 | 0.17% |
| ARXIS SECURITIES LLC | 13,039 | $25,000 | 0.03% |
| EQUITEC SPECIALISTS, LLC | 65,600 | $127,000 | 0.03% |
| Acrospire Investment Management LLC | 13,100 | $25,000 | 0.01% |
| Virtu KCG Holdings LLC | 60,313 | $117,000 | 0.00% |
| INTEGRAL DERIVATIVES, LLC | 72,200 | $140,000 | 0.00% |
| SABBY MANAGEMENT, LLC | 23,298 | $45,000 | 0.00% |
| WOLVERINE TRADING, LLC | 229,400 | $445,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,339 | $20,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,030,800 | $2,000,000 | 0.00% |